These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8924209)
1. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization. Nagashunmugam T; Friedman HM DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209 [TBL] [Abstract][Full Text] [Related]
2. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943 [TBL] [Abstract][Full Text] [Related]
3. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553 [TBL] [Abstract][Full Text] [Related]
4. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus. Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392 [TBL] [Abstract][Full Text] [Related]
5. Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. Blanc D; Patience C; Schulz TF; Weiss R; Spire B Virology; 1993 Mar; 193(1):186-92. PubMed ID: 8438565 [TBL] [Abstract][Full Text] [Related]
6. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. Gabuzda DH; Li H; Lawrence K; Vasir BS; Crawford K; Langhoff E J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):908-15. PubMed ID: 7519673 [TBL] [Abstract][Full Text] [Related]
7. The requirement for Vif of SIVmac is cell-type dependent. Zou JX; Luciw PA J Gen Virol; 1996 Mar; 77 ( Pt 3)():427-34. PubMed ID: 8601777 [TBL] [Abstract][Full Text] [Related]
8. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. Michaels FH; Hattori N; Gallo RC; Franchini G AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477 [TBL] [Abstract][Full Text] [Related]
9. Cell-free transmission of Vif mutants of HIV-1. Fan L; Peden K Virology; 1992 Sep; 190(1):19-29. PubMed ID: 1529528 [TBL] [Abstract][Full Text] [Related]
10. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines. Hevey M; Donehower LA Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173 [TBL] [Abstract][Full Text] [Related]
11. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. von Schwedler U; Song J; Aiken C; Trono D J Virol; 1993 Aug; 67(8):4945-55. PubMed ID: 8331734 [TBL] [Abstract][Full Text] [Related]
12. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. Simm M; Pekarskaya O; Potash MJ; Volsky DJ AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355 [TBL] [Abstract][Full Text] [Related]
13. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. Reddy TR; Kraus G; Yamada O; Looney DJ; Suhasini M; Wong-Staal F J Virol; 1995 Jun; 69(6):3549-53. PubMed ID: 7745702 [TBL] [Abstract][Full Text] [Related]
14. Replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus agm3 chimeric viruses in human and monkey cells: the 5' half of the HIV-1 genome is responsible for virus cytopathogenicity. Jin M; Ido E; Kuwata T; Igarashi T; Cichutek K; Kurth R; Miura T; Enose Y; Chen J; Hayami M J Gen Virol; 1996 Oct; 77 ( Pt 10)():2427-31. PubMed ID: 8887473 [TBL] [Abstract][Full Text] [Related]
15. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1. Ochsenbauer C; Wilk T; Bosch V J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414 [TBL] [Abstract][Full Text] [Related]
16. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. Gibbs JS; Regier DA; Desrosiers RC AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4(+) T cell-grafted nude mouse. Ao Z; Huang J; Tan X; Wang X; Tian T; Zhang X; Ouyang Q; Yao X J Virol Methods; 2016 Feb; 228():95-102. PubMed ID: 26640121 [TBL] [Abstract][Full Text] [Related]
18. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. Courcoul M; Patience C; Rey F; Blanc D; Harmache A; Sire J; Vigne R; Spire B J Virol; 1995 Apr; 69(4):2068-74. PubMed ID: 7884852 [TBL] [Abstract][Full Text] [Related]
19. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Akari H; Sakuragi J; Takebe Y; Tomonaga K; Kawamura M; Fukasawa M; Miura T; Shinjo T; Hayami M Arch Virol; 1992; 123(1-2):157-67. PubMed ID: 1550494 [TBL] [Abstract][Full Text] [Related]